We are live on ! Find out more
VYLD

Inverse VIX Short-Term Futures ETNs due March 22 2045

1 hedge funds and large institutions have $98.4M invested in Inverse VIX Short-Term Futures ETNs due March 22 2045 in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 (0)

1% less capital invested

Capital invested by funds: $98.9M → $98.4M (-$527K)

1.28% less ownership

Funds ownership: 99.75%98.48% (-1.3%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$1.22M

VYLD Hedge Fund Activity: Q2 2025 in Review

1 of the 7,610 institutional investors tracked by Wall St. Rank reported a position in Inverse VIX Short-Term Futures ETNs due March 22 2045 (VYLD) for Q2 2025, worth a combined $98.4M — down 0.53% from $98.9M a quarter earlier.

Fund positioning in VYLD was balanced in Q2 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was JP Morgan Chase, cutting an estimated $1.22M.

  • 1 institutional investor held Inverse VIX Short-Term Futures ETNs due March 22 2045 (VYLD) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $98.4M of Inverse VIX Short-Term Futures ETNs due March 22 2045 stock for Q2 2025, down 0.53% quarter-over-quarter.
  • 0 funds opened new Inverse VIX Short-Term Futures ETNs due March 22 2045 positions in Q2 2025 and 0 closed out.
  • The largest Inverse VIX Short-Term Futures ETNs due March 22 2045 seller in Q2 2025 was JP Morgan Chase, an estimated $1.22M sold.

Based on aggregated 13F filings for Q2 2025.